0
Articles |

Intracellular Adhesion Molecule Gly241Arg Polymorphism Has No Impact on ARDS or Septic Shock in Community-Acquired Pneumonia* FREE TO VIEW

Michael W. Quasney, MD, PhD; Grant W. Waterer, MBBS, FCCP; Mary K. Dahmer, PhD; Dawn Turner, MD; Qing Zhang, BS; Rita M. Cantor, PhD; Richard G. Wunderink, MD, FCCP
Author and Funding Information

*From the Departments of Pediatrics and Molecular Sciences, Crippled Children’s Foundation Research Center, University of Tennessee; and Methodist LeBonheur Healthcare Foundation, Memphis, TN.

Correspondence to: Michael W. Quasney, MD, PhD, College of Medicine, Department of Pediatrics, Crippled Children’s Foundation Research Center, 50 North Dunlap, Room 301, Memphis, TN 38103



Chest. 2002;121(3_suppl):85S-86S. doi:10.1378/chest.121.3_suppl.85S
Text Size: A A A
Published online

The clinical presentation and outcome following inflammatory stimuli are determined in part by the type and degree of the stimulus as well as host factors. We have previously demonstrated associations between genetic polymorphisms in the regulatory regions of tumor necrosis factor-α with both the severity of community-acquired pneumonia (CAP) and the type of clinical presentation. A recent polymorphism has been described in the gene coding for intracellular adhesion molecule (ICAM) type 1, which alters a glycine at position 241 to an arginine. This polymorphism is associated with polymyalgia rheumatica and giant-cell arteritis, common inflammatory diseases involving the synovium and extracranial branches of the aorta. Both of these disorders have elevated levels of ICAM-1, and it is hypothesized that the G241R mutation might allow for more effective binding of ICAM-1 to Mac-1, thereby enhancing the inflammatory response. We hypothesized that this mutation may be involved in some of the complications of CAP in adults.

A prospective cohort study of 289 adults with CAP was performed. Genotyping of the ICAM-1 G241R site was done using allele-specific polymerase chain reaction. Outcome measures included mortality, septic shock (SS), ARDS, and respiratory failure (RF). Heterozygotes at the G241R site demonstrated a frequency of 8.3% in the entire study group; no RR homozygotes were detected.

The frequency of the heterozygotes in patients with SS (6.7%) and RF (5.7%) was not different from patients without these complications of CAP. Ten patients in the cohort had ARDS, and 22 patients died; all had homozygotes for the GG phenotype. We conclude that unlike the associations we have reported between tumor necrosis factor-α polymorphisms and outcome in patients with CAP, the ICAM-1 polymorphism that results in the glycine-to-arginine substitution at position 241 does not appear to play a role in SS, RF, ARDS, or mortality in adults with CAP.

Abbreviations: CAP = community-acquired pneumonia; ICAM = intracellular adhesion molecule; RF = respiratory failure; SS = septic shock

Dr. Quasney is supported in part by the Children’s Foundation of Memphis and by the American Lung Association.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543